4.4000
-0.1000
(-2.22%)
At close: April 11 at 8:02:02 AM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 3 | 3 |
Avg. Estimate | 158.55M | 159.19M | 695.03M | 708.83M |
Low Estimate | 158.27M | 156.95M | 690.92M | 692.16M |
High Estimate | 158.84M | 161.42M | 700.46M | 725.5M |
Year Ago Sales | 167.39M | 167.95M | 712.54M | 695.03M |
Sales Growth (year/est) | -5.28% | -5.22% | -2.46% | 1.99% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
398.MU | -- | -- | -- | -- |
S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
Maintains | Morgan Stanley: Underweight to Underweight | 3/6/2025 |
Maintains | Goldman Sachs: Neutral to Neutral | 11/6/2024 |
Maintains | Barclays: Underweight to Underweight | 3/7/2024 |
Maintains | Goldman Sachs: Neutral to Neutral | 3/6/2024 |
Maintains | Citigroup: Neutral to Neutral | 3/6/2024 |
Initiated | Goldman Sachs: Neutral | 12/13/2023 |